arrow
P

Pere Ginès

university of barcelona
H指数:138
被引数:7.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction-associated liver disease (MASLD)

代谢功能障碍相关肝病(MASLD)引起的失代偿期肝硬化的再代偿速率及预测因素

2026-04-010
PRE
Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation Parameter

代谢功能障碍相关脂肪性肝病5年内肝脂肪变程度的显著变化:一项基于社区研究使用控制衰减参数

2025-10-080
OAAI
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases. An international multicohort study.

PD-L1及慢性肝病患者细菌感染风险。一项国际多队列研究。

2025-09-180
OAAI
Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (vol 74, pg 1014, 2021)

诊断、评估和管理腹水、自发性细菌性腹膜炎和肝肾综合征:2021年美国肝病研究协会实践指南(第74卷,第1014页,2021年)

2025-09-010
PRE
URINE PROTEOMICS IN CIRRHOSIS AND ACUTE KIDNEY INJURY: INSIGHTS INTO THE PATHOGENESIS OF HEPATORENAL SYNDROME

肝硬化及急性肾损伤中的尿液蛋白质组学:对肝肾综合征发病机制的见解

2025-08-130
PRE
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensus

Angeli, P.; Labenz, C.; Piano, S.; Juanola, A.; Krag, A.; Caraceni, P.; Trebicka, J.; Maiwall, R.; Singh, V.; Pose, E.; 等. 肝肾综合征-急性肾损伤中的白蛋白输注:新证据挑战近期共识. 肝脏病学杂志. 2025, 待发表. [谷歌学术] [CrossRef] [PubMed]

2025-04-170
PRE
Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury- results from the ICA-GLOBAL AKI study
2025-02-010
PRE
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
2025-01-010
OAAI